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Robin Spiller, editor
Occult gastro-intestinal cause of
spastic paresis of the legs
CLINICAL PRESENTATION
A 40-year-old man with diabetes presented with difficulty in
walking and paresthesia affecting both feet. Examination revealed
pes cavus (fig 1), lower limb hypertonia, sustained ankle clonus
and symmetric hyper-reflexia. There was no muscle weakness
and cerebellar signs were absent. Routine laboratory investiga-
tions were all normal except a low vitamin E level (6.2 mmol/l,
normal 11.6–35.5 mmol/l) and other neurological investigations,
including spinal magnetic resonance imaging, analysis of cerebral
spinal fluid for oligoclonal bands, urine organic and amino acid
analysis, human T-cell lymphotrophic virus-III (HTLV-III)
serology, serum phytanic and very long chain fatty acids, were
unremarkable excluding impairments of peroxisomal functions.
He drank 40 units of alcohol a week.
The patient had a family history of Charcot–Marie–Tooth
disease type 1a (CMT1a) in his sister but tested negative for
CMT1a and had a normal neurophysiological study.Nomutations
were identified in the tocopherol transfer protein (TTP) gene.
Gastro-intestinal investigations included a small bowel biopsy
which was normal, a stool test and a computed tomography
(CT) scan of the abdomen (fig 1).
QUESTION
What is the unifying diagnosis?
See page 1080 for the answer
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Figure 1 (A) Pes cavus. (B) Abdominal
computed tomography scan showing the
calcified body and tail of the pancreas.
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